Variation in protection by BCG: implications of and for heterologous immunity

1995/11/01 by Paul Fine, P.E.M. Fine · 5 citations
Immunology and Microbiology · Medicine · #Immune responses and vaccinations #Pneumonia and Respiratory Infections #Tuberculosis Research and Epidemiology

paper · doi:10.1016/s0140-6736(95)92348-9

crossref issued 1995/11/01 · crossref published 1995/11/01 · crossref published-print 1995/11/01 · openalex publication_date 1995/11/01 · crossref created 2003/10/11 · crossref deposited 2023/04/27 · openalex created_date 2025/10/10 · crossref indexed 2026/07/16 · openalex updated_date 2026/07/29

Citations

• Efficacy of BCG Vaccine in the Prevention of Tuberculosis
• Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
• Protective effect of BCG vaccination in infant Asians: a case-control study.

Cited by

• Uses and abuses of meta-analysis
• Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
• Nanotechnology based devices and applications in medicine: An overview
• Genome plasticity of BCG and impact on vaccine efficacy
• BCG vaccine [wikipedia]